TB Research

Early cellular mechanism of type I interferon-driven susceptibility to tuberculosis

Dmitri I. Kotov, Ophelia V. Lee, Stefan A. Fattinger, Charlotte A. Langner, Jaresley V. Guillen, Joshua M. Peters, Andres Moon, Eileen M. Burd, et al. (13 authors)

bioRxiv (Cold Spring Harbor Laboratory) · 2022-10

Abstract

Summary Mycobacterium tuberculosis ( Mtb ) causes 1.6 million deaths annually. Active tuberculosis correlates with a neutrophil-driven type I interferon (IFN) signature, but the cellular mechanisms underlying tuberculosis pathogenesis remain poorly understood. We found interstitial macrophages (IMs) and plasmacytoid dendritic cells (pDCs) are dominant producers of type I IFN during Mtb infection in mice and non-human primates, and pDCs localize near human Mtb granulomas. Depletion of pDCs reduces Mtb burdens, implicating pDCs in tuberculosis pathogenesis. During IFN-driven disease, we observe abundant DNA-containing neutrophil extracellular traps (NETs) known to activate pDCs. Cell type-specific disruption of the type I IFN receptor suggests IFNs act on IMs to inhibit Mtb control. Single cell RNA-seq indicates type I IFN-responsive cells are defective in their response to IFN γ , a cytokine critical for Mtb control. We propose pDC-derived type I IFNs act on IMs to drive bacterial replication, further neutrophil recruitment, and active tuberculosis disease.

MeSH terms

  • Tuberculosis
  • Mycobacterium tuberculosis
  • Pathogenesis
  • Immunology
  • Biology
  • Interferon
  • Interferon type I
  • Cytokine
  • Neutrophil extracellular traps
  • Cell type
  • Cell
  • Extracellular
  • Mechanism (biology)
  • Virology